Patent Assignment
Reel/Frame 068608/0686
Assignment of Assignor's Interest
Recorded: 2024-09-17
Pages: 13
Assignor
YEAGER, JAMES L.
Executed: 2024-09-03
Assignee
MEZZION PHARMA CO., LTD.
C&H BUILDING, 3RD FLOOR, 35, TEHERAN-RO 87-GIL, GANGNAM-GU, 135-879, KOREA, REPUBLIC OF
Covered Properties
(18)
Methods of Improving Myocardial Performance in Fontan Patients Using Udenafil Compositions
Application:
62/186,132 →
Methods of Improving Myocardial Performance in Fontan Patients Using Udenafil Compositions
Methods of Improving Myocardial Performance in Fontan Patients Using Udenafil Compositions
Methods of Improving Myocardial Performance in Fontan Patients Using Udenafil Compositions
Application:
16/146,762 →
Publication:
US 2019/0030037
Methods of Improving Myocardial Performance in Fontan Patients Using Udenafil Compositions
Application:
16/147,153 →
Publication:
US 2019/0030038
Methods of Improving Myocardial Performance in Fontan Patients Using Udenafil Compositions
Application:
16/751,979 →
Methods of Improving Myocardial Performance in Fontan Patients Using Udenafil Compositions
Application:
17/020,674 →
Publication:
US 2023/0095034
Methods of Improving Myocardial Performance in Fontan Patients Using Udenafil Compositions
Methods of Improving Myocardial Performance in Fontan Patients Using Udenafil Compositions
Application:
18/766,315 →
Publication:
US 2025/0064817
Methods of Improving Exercise Performance in Fontan Patients Using Udenafil Compositions
Application:
62/905,350 →
Methods of Improving Exercise Performance in Fontan Patients Using Udenafil Compositions
Application:
62/936,497 →
Methods of Improving Exercise Performance, Single Ventricular Performance, and Myocardial Performance Index (Mpi) in Single Ventricle Heart Disease, Using Udenafil Compositions
Application:
63/023,070 →
Methods and Compositions for Improving Exercise Performance, Single Ventricular Performance, Cardiac Output and Myocardial Performance Index (Mpi) in Single Ventricular Heart Disease, Using Udenafil Compositions
Methods and Compositions for Treating Fibrotic Liver Diseases, Using Udenafil Compositions
Application:
63/233,133 →
Methods and Compositions for Treating Fibrotic Liver Conditions, Using Udenafil Compositions
Application:
17/887,091 →
Publication:
US 2023/0218622
Methods and Compositions for Improving Exercise Performance
Application:
63/291,858 →
Methods and compositions for improving exercise performance
Application:
17/803,841 →
Publication:
US 2024/0285630
Methods of Improving Myocardial Performance in Fontan Patients Using Udenafil Compositions
Application:
62/036,506 →
Related Assignments
(11)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 3, 2015
From: YEAGER, JAMES L.
To: MEZZION PHARMA CO., LTD.
Reel/Frame 034879/0691 →
Assignment of Assignor's Interest
May 22, 2017
From: GOLDBERG, DAVID; PARIDON, STEPHEN
To: THE CHILDREN'S HOSPITAL OF PHILADELPHIA
Reel/Frame 042455/0603 →
Assignment of Assignor's Interest
Jun 14, 2017
From: YEAGER, JAMES L.
To: MEZZION PHARMA CO., LTD.
Reel/Frame 042708/0978 →
Assignment of Assignor's Interest
Aug 21, 2020
From: GOLDBERG, DAVID; PARIDON, STEPHEN
To: THE CHILDREN'S HOSPITAL OF PHILADELPHIA
Reel/Frame 053559/0185 →
Assignment of Assignor's Interest
Oct 29, 2020
From: GOLDBERG, DAVID; PARIDON, STEPHEN
To: THE CHILDREN'S HOSPITAL OF PHILADELPHIA
Reel/Frame 054208/0932 →
Assignment of Assignor's Interest
Jun 8, 2023
From: YEAGER, JAMES L.
To: MEZZION PHARMA CO., LTD.
Reel/Frame 063895/0033 →
Confirmatory License
Oct 13, 2023
From: CHILDREN'S HOSP OF PHILADELPHIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 065238/0069 →
Assignment of Assignor's Interest
Dec 21, 2023
From: YEAGER, JAMES L.; GOLDBERG, DAVID; PARIDON, STEPHEN
To: MEZZION PHARMA CO., LTD.; CHILDREN'S HOSPITAL OF PHILADELPHIA
Reel/Frame 065927/0735 →
Assignment of Assignor's Interest
Mar 12, 2024
From: YEAGER, JAMES L.
To: MEZZION PHARMA CO., LTD.
Reel/Frame 066736/0848 →
Assignment of Assignor's Interest
Apr 17, 2024
From: YEAGER, JAMES L.
To: MEZZION PHARMA CO., LTD.
Reel/Frame 067136/0212 →
Assignment of Assignor's Interest
Apr 24, 2024
From: YEAGER, JAMES L.
To: MEZZION PHARMA CO., LTD.
Reel/Frame 067203/0973 →